Results 51 to 60 of about 5,681,152 (203)
Blood biomarkers in patients with bicuspid aortic valve disease [PDF]
Patients with a bicuspid aortic valve (BAV) are at risk of developing valve deterioration and aortic dilatation. We aimed to investigate whether blood biomarkers are associated with disease stage in patients with BAV.Serum levels of high sensitivity C-reactive protein (hsCRP), high sensitivity troponin T (hsTnT), N-terminal pro-B-type natriuretic ...
Lidia R. Bons +14 more
openaire +6 more sources
Challenging Anatomies for TAVR—Bicuspid and Beyond
Transcatheter aortic valve replacement has emerged as the standard treatment for the majority of patients with symptomatic aortic stenosis. As transcatheter aortic valve replacement expands to patients across all risk groups, optimal patient selection ...
Mohammed Saad +4 more
doaj +1 more source
PATHOPHYSIOLOGY, INVESTIGATIONS, AND TREATMENT OF PATIENTS WITH BICUSPID AORTIC VALVE [PDF]
Bicuspid aortic valve is a congenital anomaly of the heart in which the aortic valve has two loops instead of the normal three. It causes valve degeneration and is associated with dilation of the aorta.
Elsaka, O. +11 more
core +2 more sources
Background: Isolated aortic valve disease (IAVD) has traditionally been a disease of elderly, etiology being either senile degeneration of a tricuspid aortic valve or calcification of a bicuspid aortic valve.
Ankit Kumar Sahu +7 more
doaj +1 more source
A unifying device–cardiovascular interface framework is presented to classify implantable cardiovascular technologies as intracardiovascular blood‐contacting systems or extracardiovascular tissue‐only and blood‐handling architectures. Cross‐class comparison across shared semiquantitative criteria, including blood‐contact burden, biomimicry ...
Bergo Nicolò +7 more
wiley +1 more source
Valve-preserving surgery on the bicuspid aortic valve [PDF]
Valve repair has emerged as an important intervention for the management of bicuspid aortic valve disease. This systematic review aims to assess the safety, efficacy and durability of bicuspid aortic valve repair.
Whistance, Robert N +4 more
core +1 more source
Introduction: Untreated congenital aortic coarctation and valvular abnormalities are rare in an adult patient and require complex management. Report: A 68 year old woman with congenital aortic coarctation and bicuspid aortic valve with severe aortic ...
Monica M. Matsumoto, Ross Milner
doaj +1 more source
Heterozygous Variants in LRP1 Cause a Neurodevelopmental Disorder With Congenital Heart Defects
ABSTRACT LRP1 encodes the low‐density lipoprotein (LDL) receptor‐related protein 1 (LRP1), a transmembrane protein involved in endocytosis and activation of multiple signaling pathways. LRP1 variants have been implicated in the pathogenesis of congenital heart defects (CHD), Alzheimer's disease, and neurodevelopmental disorders (NDD).
Alyssa L. Rippert +31 more
wiley +1 more source
Diagnosis And Treatment Of Bicuspid Aortic Valve Disease
Bicuspid aortic valve disease is the most common congenital cardiac anomaly. The prevalence in the general population is between 0.46% and 1.37%. There is significantly high cardiac morbidity associated with bicuspid aortic valve disease, predominantly ...
Ercan Aydin +3 more
core +1 more source
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. [PDF]
BACKGROUND: Transcatheter aortic-valve replacement (TAVR) is the recommended therapy for patients with severe aortic stenosis who are not suitable candidates for surgery. The outcomes beyond 1 year in such patients are not known.
Makkar, Raj R +26 more
core +1 more source

